跳至主要内容
临床试验/ISRCTN99046537
ISRCTN99046537已完成不适用

Comparison of quinine, artemether lumefantrine and dihydroartemisinin piperaquine for retreatment of recurrent malaria in Ugandan children

ganda Malaria Surveillance Project (Uganda)0 个研究点目标入组 260 人开始时间: 2008年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Males and females aged between 1 and 5 years inclusive
  • 2. Recurrent Plasmodium falciparum infection after treatment with ACTs in a related main study
  • 3. Parents' or guardians? willingness and ability to comply with the study protocol for the duration of the trial

排除标准

  • 1. Known hypersensitivity to the study drugs
  • 2. Severe malaria
  • 3. Danger signs:
  • 3.1. Not able to drink or breast-feed
  • 3.2. Vomiting (greater than twice in 24 hours)
  • 3.3. Recent history of convulsions (greater than 1 in 24 hours)
  • 3.4. Unconscious state
  • 3.5. Unable to sit or stand
  • 4. Early treatment failure in the main study

研究者

发起方
ganda Malaria Surveillance Project (Uganda)

相似试验